Ketamine Compared With Midazolam for Suicidal Thoughts in Bipolarity-Related Depression
About this title
Ketamine for Suicidality in Bipolar Depression
Read the official source — NCT01944293Researchers compared ketamine and Midazolam to find out how the approaches affected suicidal thoughts in people with bipolarity during a depressive episode.
Understand this study
What did researchers investigate?
Researchers compared ketamine and Midazolam to find out how the approaches affected suicidal thoughts in people with bipolarity during a depressive episode.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 16
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01944293
- Official title
Show the full official title
Ketamine vs. Midazolam in Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
New York
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared ketamine and Midazolam to find out how the approaches affected suicidal thoughts in people with bipolarity during a depressive episode.
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including ketamine and Midazolam.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
